ThirdLaw Molecular LLC has pioneered the development of Spiroligomer™ molecules and is developing this innovative, patent-protected, therapeutic modality into a new class of more targeted medicines. The mission of the Company is to create a revolutionary category of molecules that transform how diseases are diagnosed and treated – more safely and effectively.
Company Details
- Employees
- 14
- Founded
- -
- Address
- 512 E. Township Line Road,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://thirdlawtx.com
- Keywords
- Tantigen Bio.
- HQ
- Blue Bell, PA
Thirdlaw Molecular Questions
Thirdlaw Molecular's website is http://thirdlawtx.com
Thirdlaw Molecular's LinkedIn profile is https://www.linkedin.com/company/thirdlaw-molecular
Thirdlaw Molecular has
14 employees.
View email and phone details for 14
employees at Thirdlaw Molecular.
Thirdlaw Molecular's industry is
Biotechnology Research
Thirdlaw Molecular's top competitors are
Patwell Pharmaceutical Solutions, Llc,
Hula Therapeutics,
Sfa Therapeutics,
Aclaris Therapeutics, Inc.,
Tantigen Bio,
Eliksa Therapeutics,
Enalare Therapeutics Inc.,
Seneca Therapeutics, Inc.,
Bucks County Herald,
Third Law.
Thirdlaw Molecular's categories are Biotechnology Research
Thirdlaw Molecular's founding year is 2020
